Refreshing results…
A Microfluidic Cancer-on-Chip Platform Predicts Drug Response Using Organotypic Tumor Slice Culture
UploadRadiosensitivity is an acquired vulnerability of PARPi-resistant BRCA1-deficient tumors
UploadMissing publications? Search for publications with a matching author name.